Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rother

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 1, 2008
C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipientsR P Rother, J Arp, J Jiang, et al.
Immunogenetics|January 1, 1995
Primate terminal complement inhibitor homologues of human CD59W L Fodor, S A Rollins, S Bianco-Caron, et al.
American Journal of Hematology|July 27, 2010
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Modupe Elebute, Richard Kelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injuryMary C Walsh, Todd Bourcier, Kazue Takahashi, et al.
Shock (Augusta, Ga.)|May 17, 2007
The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusionKai Zacharowski, Paula A Zacharowski, Peter Friedl, et al.
Journal of Virology|June 1, 1995
The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activityW L Fodor, S A Rollins, S Bianco-Caron, et al.
British Journal of Haematology|March 17, 2010
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuriaAnita Hill, Russell P Rother, Xunde Wang, et al.
British Journal of Haematology|May 28, 2008
Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuriaJörg Schubert, Peter Hillmen, Alexander Röth, et al.
Brain : a Journal of Neurology|January 11, 2008
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine modelSusan K Halstead, Femke M P Zitman, Peter D Humphreys, et al.
Circulation Research|January 10, 2009
Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complexGongxiong Wu, Weiguo Hu, Aliakbar Shahsafaei, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 1, 2008
C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipientsR P Rother, J Arp, J Jiang, et al.
Immunogenetics|January 1, 1995
Primate terminal complement inhibitor homologues of human CD59W L Fodor, S A Rollins, S Bianco-Caron, et al.
American Journal of Hematology|July 27, 2010
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Modupe Elebute, Richard Kelly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injuryMary C Walsh, Todd Bourcier, Kazue Takahashi, et al.
Shock (Augusta, Ga.)|May 17, 2007
The effects of the fibrin-derived peptide Bbeta(15-42) in acute and chronic rodent models of myocardial ischemia-reperfusionKai Zacharowski, Paula A Zacharowski, Peter Friedl, et al.
Journal of Virology|June 1, 1995
The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activityW L Fodor, S A Rollins, S Bianco-Caron, et al.
British Journal of Haematology|March 17, 2010
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuriaAnita Hill, Russell P Rother, Xunde Wang, et al.
British Journal of Haematology|May 28, 2008
Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuriaJörg Schubert, Peter Hillmen, Alexander Röth, et al.
Brain : a Journal of Neurology|January 11, 2008
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine modelSusan K Halstead, Femke M P Zitman, Peter D Humphreys, et al.
Circulation Research|January 10, 2009
Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complexGongxiong Wu, Weiguo Hu, Aliakbar Shahsafaei, et al.
Pageof 13